Will AbbVie Q2 Global Rinvoq net revenues be above $2.7B?
YesY-NNo
Position$4−$101$106
Holders4+13
Trades7+25
YesΔ Y−NNo
Track record
Avg settle win rate35.0%
−29.0 pp
64.0% Cost basis
Median cost vs price×1.17
+0.17×
×1.00 Top-20 avg cost vs price×1.21
+0.21×
×1.00 Flow
Recent buyer dominance0.00
−1.00
1.00 Time-norm taker flow██
·
██ Position health
Unrealized PnL-17.2%
−17.2 pp
-0.0% Underwater %100.0%
+0.0 pp
100.0% Crowd
New wallets %0.0%
+0.0 pp
0.0%